DKK2 and cervical carcinoma: The methylation rate of the DKK2 promoter was 76.5% in cervical cancer specimens with lymph node metastasis, and only 45.2% in cervical cancer specimens without lymph node metastasis, indicating a significant difference between the 2 groups.